HLA-DR and B7-2 (CD86) monocyte expressions after major cancer surgery: Profile in sepsis

Minerva Anestesiologica

Volumn 77, Issue 5, 2011, Pages 522-527

  Mokart, D ^a   Textoris, J ^b   Chow Chine, L ^a   Brun, J P ^a   Sannini, A ^a   Turrini, O ^a   Blache, J L ^a   Arnoulet, C ^a   Sainty, D ^a   Leone, M ^b  

^a INSTITUT PAOLI CALMETTES   (France)

^b HÔPITAL NORD   (France)

Author keywords

CD86; HLA DR; Monocytes; Neoplasms, surgery; Sepsis

Indexed keywords

CD86 ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR SURGERY; MALE; MONOCYTE; OBSERVATIONAL STUDY; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEPSIS;

ADULT; AGED; ANTIGENS, CD86; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; MONOCYTES; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; SEPSIS; SURGICAL PROCEDURES, ELECTIVE;

EID: 79957654532     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Cheadle WG, Mercer-Jones M, Heinzelmann M, Polk HC, Jr. Sepsis and septic complications in the surgical patient: who is at risk? Shock 1996;6(Suppl 1):S6-S9.
2. Lukaszewicz AC, Faivre V, Payen D. Is monocyte HLA-DR expression monitoring a useful tool to predict the risk of secondary infection? Minerva Anestesiol 2010;76:737-43.
3. Schneider C, von AS, Zedler S, Schinkel C, Hartung T, Faist E. Perioperative recombinant human granulocyte colony-stimulating factor (Filgrastim) treatment prevents immunoinflammatory dysfunction associated with major surgery. Ann Surg 2004;239:75-81.
4. Cheadle WG, Hershman MJ, Wellhausen SR, Polk HC, Jr. HLA-DR antigen expression on peripheral blood monocytes correlates with surgical infection. Am J Surg 1991;161:639-45.
5. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson\ PF, Polk HC, Jr. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 1990;77:204-7.
6. Wakefield CH, Carey PD, Foulds S, Monson JR, Guillou PJ. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg 1993;80:205-9.
7. Lukaszewicz AC, Faivre V, Villa F, Payen D. Anti-inflammatory profile of circulating immune cells after surgery for seizure. Minerva Anestesiol 2010;76:477-84.
8. Wolk K, Kunz S, Crompton NE, Volk HD, Sabat R. Mul- tiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance. J Biol Chem 2003;278:18030-6.
9. Reiser H, Stadecker MJ. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med 1996;335:1369-77.
10. Zang X, Allison JP. The B7 family and cancer therapy: costimulation and coinhibition. Clin Cancer Res 2007;13(18 Pt 1):5271-9.
11. Rothstein DM, Sayegh MH. T-cell costimulatory pathways in allograft rejection and tolerance. Immunol Rev 2003;196:85-108.
12. Honstettre A, Meghari S, Nunes JA, Lepidi H, Raoult D, Olive D et al. Role for the CD28 molecule in the control of Coxiella burnetii infection. Infect Immun 2006;74:1800-8.
13. Nolan A, Weiden M, Kelly A, Hoshino Y, Hoshino S, Mehta N et al. CD40 and CD80/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis. Am J Respir Crit Care Med 2008;177:301-8.
14. Flohe S, Lendemans S, Schade FU, Kreuzfelder E, Waydhas C. Influence of surgical intervention in the immune response of severely injured patients. Intensive Care Med 2004;30:96-102.
15. Hensler T, Hecker H, Heeg K, Heidecke CD, Bartels H, Barthlen W et al. Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun 1997;65:2283-91.
16. Manjuck J, Saha DC, Astiz M, Eales LJ, Rackow EC. Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients. J Lab Clin Med 2000;135:153-60.
17. Mokart D, Leone M, Sannini A, Brun JP, Tison A, Delpero JR et al. Predictive perioperative factors for developing severe sepsis after major surgery. Br J Anaesth 2005;95:776-81.
18. Velasco E, Thuler LC, Martins CA, Dias LM, Conalves VM. Risk factors for infectious complications after abdominal surgery for malignant disease. Am J Infect Control 1996;24:1-6.
19. Charlson ME, Sax FL, MacKenzie CR, Braham RL, Fields SD, Douglas RG, Jr. Morbidity during hospitalization: can we predict it? J Chronic Dis 1987;40:705-12.
20. Keats AS. The ASA classification of physical status--a recapitulation. Anesthesiology 1978;49:233-6.
21. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/ North American multicenter study. JAMA 1993;270:2957-63.
22. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
23. Torres A, Ewig S, Lode H, Carlet J. Defining, treating andpreventing hospital acquired pneumonia: European perspective. Intensive Care Med 2009;35:9-29.
24. Franke A, Lante W, Kurig E, Zoller LG, Weinhold C, Markewitz A. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood? Eur J Cardiothorac Surg 2006;30:64-71.
25. Ayala A, Chaudry IH. Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock 1996;6 Suppl 1:S27-S38.
26. Mokart D, Capo C, Blache JL, Delpero JR, Houvenaeghel G, Martin C et al. Early postoperative compensatory anti-inflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer. Br J Surg 2002;89:1450-6.
27. Fumeaux T, Pugin J. Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Respir Crit Care Med 2002;166:1475-82.
28. Oczenski W, Krenn H, Jilch R, Watzka H, Waldenberger F, Koller U et al. HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery. Intensive Care Med 2003;29:1253-7.
29. Janeway CA, Jr., Bottomly K. Signals and signs for lymphocyte responses. Cell 1994;76:275-85.
30. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 2009;180:640-8.
31. Ugurel S, Uhlig D, Pfohler C, Tilgen W, Schadendorf D, Reinhold U. Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients. Cancer Immunol Immunother 2004;53:551-9.
32. Liu ZX, Hiwatashi N, Noguchi M, Toyota T. Increased expression of costimulatory molecules on peripheral blood monocytes in patients with Crohn's disease. Scand J Gastroenterol 1997;32:1241-6.
33. Ruetzler K, Kovaci B, Güloglu E, Kabon B, Fleischmann E, Kurz A et al. Forced-Air and a Novel Patient-Warming System(vitalHEAT vH2) Comparably Maintain Normothermia During Open Abdominal Surgery. Anesth Analg 2010 [Epub ahead of print]
34. Fleischmann E, Marschalek C, Schlemitz K, Dalton JE, Gruenberger T, Herbst F et al. Nitrous oxide may not increase the risk of cancer recurrence after colorectal surgery: a follow-up of a randomized controlled trial. BMC Anesthesiol 2009;9:1.
35. Ratnaraj J, Kabon B, Talcott MR, Sessler DI, Kurz A. Supplemental oxygen and carbon dioxide each increase subcutaneous and intestinal intramural oxygenation. Anesth Analg 2004;99:207-11.